Bioscience Plc Arix serves as Executive at LogicBio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Bioscience Plc Arix has executed 12 insider transactions totaling $29.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 28, 2020 involved selling 366,591 shares valued at $7.8M.
Bioscience Plc Arix currently holds 2,193,704 shares of LogicBio Therapeutics, Inc. (LOGC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioscience Plc Arix has been a net buyer of LOGC stock. They have purchased $16.0M and sold $13.1M worth of shares.
Bioscience Plc Arix's most recent insider trade was on May 28, 2020, when they sold 366,591 shares at $21.33 per share.
Get notified when new Form 4 filings are submitted
| $22.39 |
| Discretionary |
| Mar 16, 2020 | IMRA | $0 | Conversion | 1,367,058 | $N/A | Discretionary |
| Mar 16, 2020 | IMRA | $3.0M | Purchase | 187,500 | $16.00 | Discretionary |
| Dec 10, 2019 | HARP | $2.2M | Sale | 131,696 | $16.91 | Discretionary |
| Dec 9, 2019 | HARP | $483.8K | Sale | 26,438 | $18.30 | Discretionary |
| Dec 9, 2019 | HARP | $1.4M | Sale | 77,316 | $18.12 | Discretionary |
| Dec 6, 2019 | HARP | $914.5K | Sale | 47,752 | $19.15 | Discretionary |
| Feb 12, 2019 | HARP | $0 | Conversion | 2,463,548 | $N/A | Discretionary |
| Feb 12, 2019 | HARP | $6.0M | Purchase | 428,571 | $14.00 | Discretionary |
| Oct 23, 2018 | LOGC | $7.0M | Purchase | 700,000 | $10.00 | Discretionary |
| Oct 23, 2018 | LOGC | $0 | Conversion | 2,279,023 | $N/A | Discretionary |